Pneumonia: the leading killer of children

In Senegal, for example, a public-private partnership was formed to expand antibiotic treatment for pneumonia in a communitybased approach.17 With impressive results from a pilot programme, the Ministry of Health, with its partners, is now currently expanding treatment coverage to 18 districts, to c...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2006-09, Vol.368 (9541), p.1048-1050
Main Authors: Wardlaw, Tessa, Salama, Peter, Johansson, Emily White, Mason, Elizabeth
Format: Article
Language:English
Subjects:
Anti-Bacterial Agents - therapeutic use
Antibiotics
Child Mortality
Child, Preschool
Children & youth
Global Health
Humans
Infant
Infant, Newborn
Pneumococcal Vaccines
Pneumonia
Pneumonia - drug therapy
Pneumonia - mortality
Pneumonia - prevention & control
Preventive Health Services - economics
Public private partnerships
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In Senegal, for example, a public-private partnership was formed to expand antibiotic treatment for pneumonia in a communitybased approach.17 With impressive results from a pilot programme, the Ministry of Health, with its partners, is now currently expanding treatment coverage to 18 districts, to cover about half the under-5 population.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(06)69334-3